PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION SUITABLE FOR REDUCING OR PREVENTING INCREASED THROMBOCYTE-AGGREGATION CAPABILITY

PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION SUITABLE FOR REDUCING OR PREVENTING INCREASED THROMBOCYTE-AGGREGATION CAPABILITY

The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min -diethoxy-benzyl)-6,7-diethoxy-3,4-dihydro-isoquinoline or (3 min ,4 min -diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophyllin-7-acetate or its monohydrate as active ing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MARMAROSI,TAMASNE,HU, KAPUI,ZOLTAN,HU, HERMECZ,ISTVAN,HU, VASVARINE DEBRECZY,LELLE,HU, HORVATH,AGNES,HU, TARDOS,LASZLO,HU
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min -diethoxy-benzyl)-6,7-diethoxy-3,4-dihydro-isoquinoline or (3 min ,4 min -diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophyllin-7-acetate or its monohydrate as active ingredient for the manufacture of medicaments for use in the treatment or prevention of conditions resulting from increased thrombocyte - aggregatory activity as a consequence of decreased prostacyclin release.